MARKET PULSE-Prana Biotechnology, BlackBerry, Novartis

Mon Mar 31, 2014 7:56am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures rose on Monday, indicating the S&P 500 will climb for a second straight session, ahead of a speech by Federal Reserve Chair Janet Yellen. Dow Jones industrial average futures were up 0.29 percent at 16,287, S&P 500 futures were up 0.40 percent at 1,857.8 and Nasdaq 100 futures were up 0.44 percent at 3,578.75.

** MEDTRONIC INC, Friday close $60.41, +1.80 pct premarket

A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic product.

** BLACKBERRY LTD, Friday close $8.41, -1.07 pct premarket

The company reported a smaller-than-expected loss on Friday as new chief executive John Chen slashed costs, but a 64 percent drop in revenue underscored the challenge Chen faces in turning around the struggling smartphone maker.

** PRANA BIOTECHNOLOGY LTD, Friday close $9.86, -61.87 pct premarket

The company said its experimental drug to treat Alzheimer's disease failed to meet the main goal of a mid-stage study in patients with a mild form of the condition.   Continued...